世界のOAB治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global OAB Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5902
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・OAB治療の市場動向
・企業の競争状況、市場シェア
・OAB治療の種類別市場規模と予測2016-2027（抗コリン作用薬、ミラベグロン、ボトックス）
・OAB治療の用途別市場規模と予測2016-2027（特発性過活動膀胱、神経性過活動膀胱）
・OAB治療の北米市場規模2016-2027（アメリカ、カナダ）
・OAB治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・OAB治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・OAB治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・OAB治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Astellas Pharma、Allergan、Pfizer、Teva (Activas)、Johnson & Johnson）
・結論

This repor mainly studies OAB (overactive bladder) treatment market. Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).

Market Analysis and Insights: Global OAB Treatment Market
The global OAB Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OAB Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OAB Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OAB Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OAB Treatment market.

Global OAB Treatment Scope and Market Size
OAB Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global OAB Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anticholinergics
Mirabegron
Botox

Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OAB Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anticholinergics
1.2.3 Mirabegron
1.2.4 Botox
1.3 Market by Application
1.3.1 Global OAB Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global OAB Treatment Market Perspective (2016-2027)
2.2 OAB Treatment Growth Trends by Regions
2.2.1 OAB Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 OAB Treatment Historic Market Share by Regions (2016-2021)
2.2.3 OAB Treatment Forecasted Market Size by Regions (2022-2027)
2.3 OAB Treatment Industry Dynamic
2.3.1 OAB Treatment Market Trends
2.3.2 OAB Treatment Market Drivers
2.3.3 OAB Treatment Market Challenges
2.3.4 OAB Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top OAB Treatment Players by Revenue
3.1.1 Global Top OAB Treatment Players by Revenue (2016-2021)
3.1.2 Global OAB Treatment Revenue Market Share by Players (2016-2021)
3.2 Global OAB Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by OAB Treatment Revenue
3.4 Global OAB Treatment Market Concentration Ratio
3.4.1 Global OAB Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OAB Treatment Revenue in 2020
3.5 OAB Treatment Key Players Head office and Area Served
3.6 Key Players OAB Treatment Product Solution and Service
3.7 Date of Enter into OAB Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 OAB Treatment Breakdown Data by Type
4.1 Global OAB Treatment Historic Market Size by Type (2016-2021)
4.2 Global OAB Treatment Forecasted Market Size by Type (2022-2027)

5 OAB Treatment Breakdown Data by Application
5.1 Global OAB Treatment Historic Market Size by Application (2016-2021)
5.2 Global OAB Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America OAB Treatment Market Size (2016-2027)
6.2 North America OAB Treatment Market Size by Type
6.2.1 North America OAB Treatment Market Size by Type (2016-2021)
6.2.2 North America OAB Treatment Market Size by Type (2022-2027)
6.2.3 North America OAB Treatment Market Size by Type (2016-2027)
6.3 North America OAB Treatment Market Size by Application
6.3.1 North America OAB Treatment Market Size by Application (2016-2021)
6.3.2 North America OAB Treatment Market Size by Application (2022-2027)
6.3.3 North America OAB Treatment Market Size by Application (2016-2027)
6.4 North America OAB Treatment Market Size by Country
6.4.1 North America OAB Treatment Market Size by Country (2016-2021)
6.4.2 North America OAB Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe OAB Treatment Market Size (2016-2027)
7.2 Europe OAB Treatment Market Size by Type
7.2.1 Europe OAB Treatment Market Size by Type (2016-2021)
7.2.2 Europe OAB Treatment Market Size by Type (2022-2027)
7.2.3 Europe OAB Treatment Market Size by Type (2016-2027)
7.3 Europe OAB Treatment Market Size by Application
7.3.1 Europe OAB Treatment Market Size by Application (2016-2021)
7.3.2 Europe OAB Treatment Market Size by Application (2022-2027)
7.3.3 Europe OAB Treatment Market Size by Application (2016-2027)
7.4 Europe OAB Treatment Market Size by Country
7.4.1 Europe OAB Treatment Market Size by Country (2016-2021)
7.4.2 Europe OAB Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific OAB Treatment Market Size (2016-2027)
8.2 Asia-Pacific OAB Treatment Market Size by Type
8.2.1 Asia-Pacific OAB Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific OAB Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific OAB Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific OAB Treatment Market Size by Application
8.3.1 Asia-Pacific OAB Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific OAB Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific OAB Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific OAB Treatment Market Size by Region
8.4.1 Asia-Pacific OAB Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific OAB Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America OAB Treatment Market Size (2016-2027)
9.2 Latin America OAB Treatment Market Size by Type
9.2.1 Latin America OAB Treatment Market Size by Type (2016-2021)
9.2.2 Latin America OAB Treatment Market Size by Type (2022-2027)
9.2.3 Latin America OAB Treatment Market Size by Type (2016-2027)
9.3 Latin America OAB Treatment Market Size by Application
9.3.1 Latin America OAB Treatment Market Size by Application (2016-2021)
9.3.2 Latin America OAB Treatment Market Size by Application (2022-2027)
9.3.3 Latin America OAB Treatment Market Size by Application (2016-2027)
9.4 Latin America OAB Treatment Market Size by Country
9.4.1 Latin America OAB Treatment Market Size by Country (2016-2021)
9.4.2 Latin America OAB Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa OAB Treatment Market Size (2016-2027)
10.2 Middle East & Africa OAB Treatment Market Size by Type
10.2.1 Middle East & Africa OAB Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa OAB Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa OAB Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa OAB Treatment Market Size by Application
10.3.1 Middle East & Africa OAB Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa OAB Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa OAB Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa OAB Treatment Market Size by Country
10.4.1 Middle East & Africa OAB Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa OAB Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma OAB Treatment Introduction
11.1.4 Astellas Pharma Revenue in OAB Treatment Business (2016-2021)
11.1.5 Astellas Pharma Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan OAB Treatment Introduction
11.2.4 Allergan Revenue in OAB Treatment Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OAB Treatment Introduction
11.3.4 Pfizer Revenue in OAB Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Teva (Activas)
11.4.1 Teva (Activas) Company Details
11.4.2 Teva (Activas) Business Overview
11.4.3 Teva (Activas) OAB Treatment Introduction
11.4.4 Teva (Activas) Revenue in OAB Treatment Business (2016-2021)
11.4.5 Teva (Activas) Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson OAB Treatment Introduction
11.5.4 Johnson & Johnson Revenue in OAB Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global OAB Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anticholinergics
Table 3. Key Players of Mirabegron
Table 4. Key Players of Botox
Table 5. Global OAB Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global OAB Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global OAB Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global OAB Treatment Market Share by Regions (2016-2021)
Table 9. Global OAB Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global OAB Treatment Market Share by Regions (2022-2027)
Table 11. OAB Treatment Market Trends
Table 12. OAB Treatment Market Drivers
Table 13. OAB Treatment Market Challenges
Table 14. OAB Treatment Market Restraints
Table 15. Global OAB Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global OAB Treatment Market Share by Players (2016-2021)
Table 17. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OAB Treatment as of 2020)
Table 18. Ranking of Global Top OAB Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by OAB Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players OAB Treatment Product Solution and Service
Table 22. Date of Enter into OAB Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OAB Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global OAB Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global OAB Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global OAB Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global OAB Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global OAB Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global OAB Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global OAB Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America OAB Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America OAB Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America OAB Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America OAB Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America OAB Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America OAB Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe OAB Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe OAB Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe OAB Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe OAB Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe OAB Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe OAB Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific OAB Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific OAB Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific OAB Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific OAB Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific OAB Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific OAB Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America OAB Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America OAB Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America OAB Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America OAB Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America OAB Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America OAB Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa OAB Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa OAB Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa OAB Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa OAB Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa OAB Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa OAB Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Astellas Pharma Company Details
Table 63. Astellas Pharma Business Overview
Table 64. Astellas Pharma OAB Treatment Product
Table 65. Astellas Pharma Revenue in OAB Treatment Business (2016-2021) & (US$ Million)
Table 66. Astellas Pharma Recent Development
Table 67. Allergan Company Details
Table 68. Allergan Business Overview
Table 69. Allergan OAB Treatment Product
Table 70. Allergan Revenue in OAB Treatment Business (2016-2021) & (US$ Million)
Table 71. Allergan Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer OAB Treatment Product
Table 75. Pfizer Revenue in OAB Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Teva (Activas) Company Details
Table 78. Teva (Activas) Business Overview
Table 79. Teva (Activas) OAB Treatment Product
Table 80. Teva (Activas) Revenue in OAB Treatment Business (2016-2021) & (US$ Million)
Table 81. Teva (Activas) Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson OAB Treatment Product
Table 85. Johnson & Johnson Revenue in OAB Treatment Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OAB Treatment Market Share by Type: 2020 VS 2027
Figure 2. Anticholinergics Features
Figure 3. Mirabegron Features
Figure 4. Botox Features
Figure 5. Global OAB Treatment Market Share by Application: 2020 VS 2027
Figure 6. Idiopathic Overactive Bladder Case Studies
Figure 7. Neurogenic Overactive Bladder Case Studies
Figure 8. OAB Treatment Report Years Considered
Figure 9. Global OAB Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global OAB Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global OAB Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global OAB Treatment Market Share by Regions (2022-2027)
Figure 13. Global OAB Treatment Market Share by Players in 2020
Figure 14. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OAB Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by OAB Treatment Revenue in 2020
Figure 16. Global OAB Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global OAB Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America OAB Treatment Market Share by Type (2016-2027)
Figure 20. North America OAB Treatment Market Share by Application (2016-2027)
Figure 21. North America OAB Treatment Market Share by Country (2016-2027)
Figure 22. United States OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe OAB Treatment Market Share by Type (2016-2027)
Figure 26. Europe OAB Treatment Market Share by Application (2016-2027)
Figure 27. Europe OAB Treatment Market Share by Country (2016-2027)
Figure 28. Germany OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific OAB Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific OAB Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific OAB Treatment Market Share by Region (2016-2027)
Figure 38. China OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America OAB Treatment Market Share by Type (2016-2027)
Figure 46. Latin America OAB Treatment Market Share by Application (2016-2027)
Figure 47. Latin America OAB Treatment Market Share by Country (2016-2027)
Figure 48. Mexico OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa OAB Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa OAB Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa OAB Treatment Market Share by Country (2016-2027)
Figure 54. Turkey OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE OAB Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Astellas Pharma Revenue Growth Rate in OAB Treatment Business (2016-2021)
Figure 58. Allergan Revenue Growth Rate in OAB Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in OAB Treatment Business (2016-2021)
Figure 60. Teva (Activas) Revenue Growth Rate in OAB Treatment Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in OAB Treatment Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の家族性大腸腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Familial Adenomatous Polyposis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5736 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、家族性大腸腺腫症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イコサペント、塩酸エフロルニチン、アスピリン、CEQ-508、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（...

世界の鼠径ヘルニア治療市場規模・現状・予測（2021年-2027年）

Global Inguinal Hernia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4368 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、鼠径ヘルニア治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オープン法ヘルニア治療、腹腔鏡検査、その他）、用途別市場規模（間接鼠径ヘルニア、直接鼠径ヘルニア）、主要地域別市場規模（北米、アメリカ、...

世界の認知症治療市場規模・現状・予測（2021年-2027年）

Global Dementia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4106 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、認知症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ドネペジル、メマンチン、リバスチグミン、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Clostridium Botulinum Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4028 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ボツリヌス菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗毒素療法、細心気道管理、人工呼吸補助）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のアルコール性肝炎治療市場規模・現状・予測（2021年-2027年）

Global Alcoholic Hepatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3776 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アルコール性肝炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、キサンチン誘導体、その他）、用途別市場規模（病院、診療所、私立治療センター）、主要地域別市場規模（北米、アメリカ...

世界の筋層浸潤性膀胱がん治療市場規模・現状・予測（2021年-2027年） Muscle invasive bladder cancer is treated by chemotherapy, radiation therapy, or a combination of the two, and anti-cancer treatment is carried out through drugs that kill cancer cells. Market Analysis and Insights: Global Muscle Invasive Bladder Cancer Treatment Market The global Muscle Invasive Bl…
世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…
世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Argininemia Treatment Market The global Argininemia Treatment market size i…